2011 annual financial data
Nektar Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -159.12%.
Operating income was -123,937,000 USD and net income was -133,978,000 USD.
Operating cash flow was -113,742,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 71,480,000 USD
- Operating income
- -123,937,000 USD
- Net income
- -133,978,000 USD
- Operating cash flow
- -113,742,000 USD